resiquimod has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catherine Jin, SL; Chang, CH; Chuang, TH; Hsu, LC; Lai, CY; Liu, YL; Lu, CH; Su, YW; Yeh, DW | 1 |
| Di, T; Li, P; Lin, Y; Liu, X; Meng, Y; Ruan, Z; Wang, M; Wang, N; Wang, Y; Xie, X; Zhang, L; Zhao, J | 1 |
2 other study(ies) available for resiquimod and Psoriasis
| Article | Year |
|---|---|
Involvement of M1 Macrophage Polarization in Endosomal Toll-Like Receptors Activated Psoriatic Inflammation.
Topics: Animals; Cell Cycle; Cell Differentiation; Computational Biology; Cytokines; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Imidazoles; Inflammation; Macrophages; Mice; Mice, Inbred BALB C; Psoriasis; THP-1 Cells; Toll-Like Receptor 7; Toll-Like Receptors | 2018 |
Suppressive effect of β,β-dimethylacryloyl alkannin on activated dendritic cells in psoriasis by the TLR7/8 pathway.
Topics: Animals; Cell Differentiation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Humans; Imidazoles; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Interleukin-23; Lithospermum; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; Naphthoquinones; Psoriasis; Skin; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2016 |